Nalmefene for Elective Reversal of Procedural Sedation in Children: Results of an Open-Label Clinical Trial

Abstract 463 Poster Session III, Monday, 5/3 (poster 207)

Background: Nalmefene is a new, long acting opioid antagonist. Its use in children for the elective reversal of emergency department procedures requiring opioid sedation has not been investigated.

Log in or create a free account to read this content

Gain free access to this article, as well as selected content from this journal and more on nature.com

Access through your institution

or

Sign in or create an account

Continue with Google

Continue with ORCiD